Compare PTCT & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | MCY |
|---|---|---|
| Founded | 1998 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 2006 | 1995 |
| Metric | PTCT | MCY |
|---|---|---|
| Price | $69.14 | $88.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | $80.65 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 915.0K | 168.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | ★ 264.48 | 15.62 |
| EPS | 7.78 | ★ 9.77 |
| Revenue | $264,734,000.00 | ★ $5,992,468,000.00 |
| Revenue This Year | N/A | $5.16 |
| Revenue Next Year | $19.30 | $5.59 |
| P/E Ratio | ★ $8.71 | $9.03 |
| Revenue Growth | ★ 36.19 | 9.44 |
| 52 Week Low | $35.95 | $48.79 |
| 52 Week High | $87.50 | $100.06 |
| Indicator | PTCT | MCY |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 51.18 |
| Support Level | $64.00 | $88.34 |
| Resistance Level | $69.23 | $93.18 |
| Average True Range (ATR) | 2.24 | 2.46 |
| MACD | 0.57 | 0.09 |
| Stochastic Oscillator | 81.53 | 53.18 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The company offers the following types of automobile coverage: collision, property damage, bodily injury (BI), comprehensive, personal injury protection (PIP), underinsured and uninsured motorist, and other hazards. Additionally, it offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages. The company has one reportable business segment, the Property and Casualty business segment.